Jennifer L Payne

Title: Innovations in Post-Partum Depression Diagnosis by Jennifer L Payne

Introduction

Jennifer L Payne is an accomplished inventor based in Baltimore, MD (US). She has made significant contributions to the field of mental health, particularly in understanding post-partum depression (PPD). Her innovative work focuses on the use of DNA methylation biomarkers to diagnose and predict the risk of PPD.

Latest Patents

Jennifer L Payne holds a patent for her invention titled "DNA methylation biomarkers of post-partum depression risk." This invention relates to the identification of biomarkers that can be used to diagnose post-partum depression or predict the risk thereof. The method involves providing a sample from a patient, measuring white blood cell type counts and DNA methylation levels of a specific panel of biomarkers, and identifying the likelihood of PPD based on these measurements. This groundbreaking approach has the potential to improve early diagnosis and treatment of PPD.

Career Highlights

Throughout her career, Jennifer has worked with prestigious institutions such as Johns Hopkins University and the University System of Maryland. Her research has contributed to a deeper understanding of the biological factors associated with post-partum depression, paving the way for more effective interventions.

Collaborations

Jennifer has collaborated with notable colleagues, including Zachary Kaminsky and Todd Gould. These partnerships have enhanced her research efforts and expanded the impact of her work in the field of mental health.

Conclusion

Jennifer L Payne's innovative approach to diagnosing post-partum depression through DNA methylation biomarkers represents a significant advancement in mental health research. Her contributions are vital for improving the lives of those affected by PPD.